Systematic review: The management of unhealed wounds and persistent perineal sinuses following proctectomy in inflammatory bowel disease - Top-Institutions - MDSpire

Systematic review: The management of unhealed wounds and persistent perineal sinuses following proctectomy in inflammatory bowel disease

  • By

  • T. Pelly

  • E. Anand

  • S. Holubar

  • P. Tozer

  • A. Hart

  • December 8, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Colorectal Surgery
    • Inflammatory Bowel Disease
    • Wound Care

  • #2

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Colorectal Surgery
    • Inflammatory Bowel Disease
    • Advanced Wound Management

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Colorectal Surgery
    • Inflammatory Bowel Disease
    • Hyperbaric Medicine

  • #4

    University of Chicago Medicine
    University of Chicago Medicine

    Chicago, IL

    Key Differentiators

    • Colorectal Surgery
    • Inflammatory Bowel Disease
    • Wound Healing Research

  • #5

    Royal London Hospital (Barts Health NHS Trust)
    Royal London Hospital (Barts Health NHS Trust)

    London, England

    Key Differentiators

    • Colorectal Surgery
    • Inflammatory Bowel Disease
    • Surgical Research

Original Source(s)

Systematic review: The management of unhealed wounds and persistent perineal sinuses following proctectomy in inflammatory bowel disease

  • by T. Pelly, E. Anand, S. Holubar, P. Tozer, A. Hart

  • December 8, 2025

Related Content

Creation and assessment of a predictive model utilizing choroid plexus imaging from brain MRI for evaluating anti-TNF-α treatment responses in Crohn’s disease

Dynamic management of traumatic brain injury in rat: injectable hydrogels and future directions

Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management